| |
| |
|
| Insider
Information: |
Young Kevin |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
55,612 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,666,186 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,612 |
|
|
| Total
Value |
$1,666,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Operating Officer |
2018-02-21 |
25,612 |
2006-02-02 |
0 |
Premium* |
|
|
Cortexyme, Inc. |
CRTX |
Director |
2019-05-13 |
30,000 |
2019-05-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2006-02-02 |
4 |
A |
$35.35 |
$1,767,500 |
D/D |
50,000 |
51,254 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
17,739 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
25,816 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2010-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
46,347 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2011-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
19,375 |
65,216 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2011-03-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
23,250 |
69,091 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2012-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
23,100 |
82,999 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2012-06-29 |
4 |
A |
$29.02 |
$21,271 |
D/D |
733 |
73,502 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2013-01-30 |
5 |
A |
$0.00 |
$0 |
D/D |
21,332 |
183,172 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
29,000 |
176,972 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2014-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
33,246 |
216,418 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Operating Officer |
• • – |
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
2,881 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Operating Officer |
• • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,810 |
9,691 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Operating Officer |
• • – |
2017-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,810 |
13,498 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Operating Officer |
• • – |
2018-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,110 |
17,186 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Operating Officer |
• • – |
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
16,152 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Operating Officer |
• • – |
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
9,460 |
25,612 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2007-07-03 |
4 |
AS |
$39.36 |
$1,180,854 |
D/D |
(30,000) |
4,681 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2007-10-09 |
4 |
AS |
$41.43 |
$1,247,215 |
D/D |
(30,000) |
4,681 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2013-09-23 |
4 |
AS |
$62.78 |
$6,288,189 |
D/D |
(100,000) |
161,840 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2013-10-23 |
4 |
AS |
$68.54 |
$5,142,000 |
D/D |
(75,000) |
161,840 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2013-11-22 |
4 |
AS |
$73.90 |
$5,575,549 |
D/D |
(75,000) |
161,840 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2013-12-20 |
4 |
AS |
$74.19 |
$5,564,453 |
D/D |
(75,000) |
161,840 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Commercial Operations |
• – – |
2014-01-23 |
4 |
AS |
$81.44 |
$8,144,150 |
D/D |
(100,000) |
216,418 |
0 |
- |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2019-05-13 |
4 |
B |
$17.00 |
$510,000 |
D/D |
30,000 |
30,000 |
2.39 |
- |
|
85 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
